Malgorzata Frak
Lublin, LU 20954, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients.
Journal: Scientific reports
Published: May 16, 2024
MicroRNA-126 selected with broad-spectrum analysis of microRNAs - a new predictive factor for the effectiveness of immunotherapy or chemoimmunotherapy in advanced NSCLC patients?
Journal: Frontiers in immunology
Published: November 26, 2023
The influence of plasma sPD-L1 concentration on the effectiveness of immunotherapy in advanced NSCLC patients.
Journal: Cancer immunology, immunotherapy : CII
Published: August 05, 2023
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.
Journal: Cancers
Published: November 16, 2022
Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer.
Journal: AMB Express
Published: March 28, 2022
Molecular and Clinical Premises for the Combination Therapy Consisting of Radiochemotherapy and Immunotherapy in Non-Small Cell Lung Cancer Patients.
Journal: Cancers
Published: January 16, 2021
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients.
Journal: Frontiers in oncology
Published: May 19, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026